Evofem Biosciences, Inc. (EVFM)

CIK 1618835 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Evofem Biosciences, Inc..

Recent SEC filings

FiledFormAccession number
Aug 14, 202610-Q0001493152-26-038328
Aug 4, 2026SCHEDULE 13D0001213900-26-084888
Jul 20, 20268-K0001493152-26-033910
Jul 14, 20268-K0001493152-26-033184
May 18, 20268-K0001493152-26-024095
May 15, 202610-Q0001493152-26-023928
Apr 30, 20268-K0001493152-26-020417
Apr 16, 20268-K0001493152-26-017082
Mar 19, 20268-K0001493152-26-011613
Mar 11, 202610-K0001493152-26-009686
Mar 11, 20268-K0001493152-26-009689
Jan 12, 20268-K0001493152-26-001886
Nov 26, 20258-K0001493152-25-025172
Nov 13, 20258-K0001493152-25-022318
Nov 13, 202510-Q0001493152-25-022275
Oct 29, 2025DEF 14A0001493152-25-020062
Oct 20, 2025PRE 14A0001493152-25-018688
Oct 20, 20258-K0001493152-25-018687
Oct 17, 20258-K0001493152-25-018454
Sep 19, 2025DEFA14A0001493152-25-014327
Sep 9, 2025DEFA14A0001641172-25-026967
Sep 8, 2025DEFM14A0001641172-25-026774
Aug 26, 20258-K0001641172-25-025530
Aug 26, 2025PREM14A0001641172-25-025582
Aug 14, 20258-K0001641172-25-023740